Skip to main content
Premium Trial:

Request an Annual Quote

GeneArt Nets Additional $800K in Expanded NCI Contract

NEW YORK (GenomeWeb News) – The National Cancer Institute has extended an existing agreement with synthetic genomics company GeneArt to produce genes for the NCI’s Mammalian Gene Collection, the company said today.
GeneArt said that it stands to gain an additional $800,000 from the expanded contract, bringing the total value of the agreement to $2.7 million in 2008.
The company said it netted $3.5 million in 2007 from the NCI contract, which was renewed earlier this year.
GeneArt said that the genes it has produced to date for the MGC are made of complex repeat motifs, are large, and are primarily rare transcripts. The company said it has recently advanced its synthesis processes and developed new production techniques to in order to produce the complex genes efficiently.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.